Announcement of Solicitation Subaward:
We are pleased to announce that Meso Scale Diagnostics, LLC, whose headquarters are in Gaithersburg, Maryland, was awarded a contract to adapt their diagnostic testing platform into a point-of-care system for diagnosis of Chlamydia infections. This highly competitive award for development of novel point-of-care tests was made based on a review of a team of experts in the fields of medical technology, sexually transmitted disease and fieldable diagnostics. This technology will represent a significant advancement in the areas of STD testing and in diagnostic devices.
Announcement of second Solicitation Subaward:
We are pleased to announce that Atlas Genetics Ltd., a UK-based healthcare company focused on providing rapid DNA diagnostics, has been awarded a contract to adapt their testing platform into a point-of-care system for diagnosis of Chlamydia infections.
Announcement of ARRA Supplement for Comparative Effectiveness Research:
An award issued under the American Recovery and Reinvestment Act (ARRA) of 2009 has been sub-contracted to Diane R. Blake, M.D. at the University of Massachusetts Medical School. Dr Blake and graduate student Wei (Tiffany) Huang, in collaboration with Dr. Gaydos, will develop a comparative-effectiveness research (CER) model for clinic-based point-of-care Chlamydia tests versus standard Chlamydia tests, and for Internet-based POC and standard tests versus clinic-based POC and standard tests. Outcomes of this CER project will provide guidance to public health officials for future recommendations of the most effective manner in which to address the chlamydia epidemic and prevent its sequelae.